intestinal microbial metabolism phosphatidylcholine cardiovascular risk abstract background recent studies animals shown mechanistic link intestinal microbial metabolism choline moiety dietary phosphatidylcholine lecithin coronary artery disease production proatherosclerotic metabolite trimethylamine-n-oxide tmao investigated relationship intestinal microbiota-dependent metabolism dietary phosphatidylcholine tmao levels adverse cardiovascular events humans methods quantified plasma urinary levels tmao plasma choline betaine levels means liquid chromatography online tandem mass spectrometry phosphatidylcholine challenge ingestion hard-boiled eggs deuterium num labeled phosphatidylcholine healthy participants suppression intestinal microbiota oral broad-spectrum antibiotics examined relationship fasting plasma levels tmao incident major adverse cardiovascular events death myocardial infarction stroke num years follow-up num patients undergoing elective coronary angiography results time-dependent increases levels tmao num isotopologue choline metabolites detected phosphatidylcholine challenge plasma levels tmao markedly suppressed administration antibiotics reappeared withdrawal antibiotics increased plasma levels tmao increased risk major adverse cardiovascular event hazard ratio highest lowest tmao quartile num num confidence interval num num num elevated tmao level predicted increased risk major adverse cardiovascular events adjustment traditional risk factors num lower-risk subgroups conclusions production tmao dietary phosphatidylcholine dependent metabolism intestinal microbiota increased tmao levels increased risk incident major adverse cardiovascular events funded national institutes health 
